Medicine
Showing 921-940 of 1,153 Results
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, digital health and generative AI, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
Clinical Associate Professor (By courtesy), UrologyBioDr. Sumit Shah is a medical oncologist specializing in the management of advanced urologic malignancies, including prostate, bladder, kidney, and testicular cancers. He serves as an investigator on numerous clinical trials, with a particular focus on novel immunotherapy agents. His academic interests also encompass digital health technologies and innovative healthcare delivery models. He has lectured internationally on the management of urologic cancers and currently serves on the National Cancer Center Network (NCCN) Panel for testicular cancer.
Dr. Shah graduated with distinction in biomedical engineering from Duke University, earned his MD from Stanford University, and completed a Master of Public Health at Harvard University. He trained in internal medicine at the University of California, San Francisco (UCSF), where he remained on faculty for one year before returning to Stanford for his fellowship in medical oncology. He now holds a faculty position in the Department of Medicine (Oncology) at Stanford.
In addition to his clinical and research roles, Dr. Shah serves as Medical Director of Digital Healthcare Integration and Director of Infusion Services at Stanford Hospital. He is also Assistant Dean of Academic Advising in the Stanford School of Medicine. -
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Husham Sharifi
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioI am a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine in Stanford University School of Medicine. In addition to seeing patients in the intensive care unit (ICU), I focus my research and clinical practice on transplant-related pulmonary fibrosis, which includes fibrotic lung disease after lung transplant or after hematopoietic cell transplant. My research applies advanced computational analysis to clinical metadata and quantitative imaging data, domains that draw on my training in engineering and bioinformatics. In the clinical setting I see patients in a Lung Graft-versus-Host-Disease (GVHD) Clinic for individuals with pulmonary complications after life-saving hematopoietic cell transplant. Our clinic is part of a national Lung GVHD Consortium comprising Stanford, Fred Hutchinson Cancer Center, University of Michigan, and MD Anderson Cancer Center. In this context I am the site co-Principal Investigator for two national clinical trials through the Lung GVHD Consortium that are funded by the National Institutes of Health. The first trial uses a home spirometry device and monitoring system to study the association of Lung GVHD with respiratory viral infections. The second trial studies the diagnostic and prognostic utility of quantitative CT scans of the chest for Lung GVHD. My goal is to fuse detailed, communicative patient care with the advances of data science in medicine that I research and study.
See my website at https://www.sharifi.com/. -
Rahul P Sharma, MBBS, FRACP
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Yelizaveta Sher, MD, FACLP
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Professor (By courtesy), Medicine - Pulmonary, Allergy & Critical Care MedicineBioDr. Sher received her BA from UC Berkeley and MD from Washington University in St. Louis. She completed Residency in Psychiatry and Fellowship in Psychosomatic Medicine at Stanford University Medical Center. She has been a part of Psychosomatic Medicine Faculty, now a Division of Medical Psychiatry, at Stanford since 2013. Her areas of clinical and research interests include psychiatric comorbidities in patients with pulmonary disorders. In particular, she specializes in mental health of patients with cystic fibrosis as well as lung and heart transplant patients. She consults on patients hospitalized on medical and surgical units as well as sees patients in outpatient clinics. She serves as the Director of Psychiatric and Psychological Services for the Adult Cystic Fibrosis Clinic and Chief of Psychosomatic Medicine Clinic. She has published many articles and book chapters and edited several books related to her fields of interest and expertise.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
